Advertisement
Screener

EPIZYME, INC. Financing Cash Flow

EPIZYME, INC. Financing Cash Flow

EPIZYME, INC. reported Financing Cash Flow of $82.21 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-08-09

  • EPIZYME, INC. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was -$257.00K, a 111.98% decline year-over-year.
  • EPIZYME, INC. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $82.46M, a 5832.59% increase year-over-year.
  • EPIZYME, INC. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $7.60M, a 94.84% decline year-over-year.
  • EPIZYME, INC. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $20.35M, a 1796.92% increase year-over-year.
  • EPIZYME, INC. net cash provided by (used in) financing activities for fiscal 2021 was $31.49M, a 87.39% decline from fiscal 2020.
  • EPIZYME, INC. net cash provided by (used in) financing activities for fiscal 2020 was $249.66M, a 12.81% decline from fiscal 2019.
  • EPIZYME, INC. net cash provided by (used in) financing activities for fiscal 2019 was $286.35M, a 240.03% increase from fiscal 2018.
  • EPIZYME, INC. net cash provided by (used in) financing activities for fiscal 2018 was $84.21M, a 45.97% decline from fiscal 2017.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2022-06-30-$257.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$82.21M
10-Q · filed 2022-08-09
$89.81M
derived: sum of 3 quarters · filed 2022-08-09
$110.16M
derived: sum of 4 quarters · filed 2022-08-09
2022-03-31$82.46M
10-Q · filed 2022-05-10
$90.06M
derived: sum of 2 quarters · filed 2022-05-10
$110.42M
derived: sum of 3 quarters · filed 2022-05-10
$112.56M
derived: sum of 4 quarters · filed 2022-08-09
2021-12-31$7.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$27.96M
derived: sum of 2 quarters · filed 2022-03-01
$30.10M
derived: sum of 3 quarters · filed 2022-08-09
$31.49M
10-K · filed 2022-03-01
2021-09-30$20.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$22.50M
derived: sum of 2 quarters · filed 2022-08-09
$23.89M
10-Q · filed 2021-11-09
$171.28M
derived: sum of 4 quarters · filed 2022-08-09
2021-06-30$2.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$3.54M
10-Q · filed 2022-08-09
$150.92M
derived: sum of 3 quarters · filed 2022-08-09
$152.00M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$1.39M
10-Q · filed 2022-05-10
$148.78M
derived: sum of 2 quarters · filed 2022-05-10
$149.85M
derived: sum of 3 quarters · filed 2022-05-10
$172.52M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$147.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$148.46M
derived: sum of 2 quarters · filed 2022-03-01
$171.13M
derived: sum of 3 quarters · filed 2022-03-01
$249.66M
10-K · filed 2022-03-01
2020-09-30$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$23.74M
derived: sum of 2 quarters · filed 2021-11-09
$102.27M
10-Q · filed 2021-11-09
$225.81M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$22.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$101.20M
10-Q · filed 2021-08-09
$224.74M
derived: sum of 3 quarters · filed 2022-03-01
$225.28M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$78.53M
10-Q · filed 2021-05-06
$202.07M
derived: sum of 2 quarters · filed 2022-03-01
$202.62M
derived: sum of 3 quarters · filed 2022-03-01
$203.23M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$123.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$124.09M
derived: sum of 2 quarters · filed 2022-03-01
$124.70M
derived: sum of 3 quarters · filed 2022-03-01
$286.35M
10-K · filed 2022-03-01
2019-09-30$543.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$1.16M
derived: sum of 2 quarters · filed 2020-11-06
$162.80M
10-Q · filed 2020-11-06
$244.54M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30$612.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$162.26M
10-Q · filed 2020-08-04
$244.00M
derived: sum of 3 quarters · filed 2021-02-23
$244.54M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$161.65M
10-Q · filed 2020-05-04
$243.39M
derived: sum of 2 quarters · filed 2021-02-23
$243.93M
derived: sum of 3 quarters · filed 2021-02-23
$244.01M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31$81.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
$82.28M
derived: sum of 2 quarters · filed 2021-02-23
$82.36M
derived: sum of 3 quarters · filed 2021-02-23
$84.21M
10-K · filed 2021-02-23
2018-09-30$539.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$624.00K
derived: sum of 2 quarters · filed 2019-10-31
$2.47M
10-Q · filed 2019-10-31
$2.57M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$85.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$1.93M
10-Q · filed 2019-08-09
$2.03M
derived: sum of 3 quarters · filed 2020-02-27
$155.05M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$1.85M
10-Q · filed 2019-05-06
$1.94M
derived: sum of 2 quarters · filed 2020-02-27
$154.96M
derived: sum of 3 quarters · filed 2020-02-27
2017-12-31$95.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$153.11M
derived: sum of 2 quarters · filed 2020-02-27
$155.87M
10-K · filed 2020-02-27
2017-09-30$153.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$155.78M
10-Q · filed 2018-11-02
2017-06-30$2.76M
10-Q · filed 2018-08-02
2016-12-31$131.36M
10-K · filed 2019-02-26
2014-06-30$531.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13
$102.47M
10-Q · filed 2014-08-13
$102.56M
derived: sum of 3 quarters · filed 2014-08-13
$101.79M
derived: sum of 4 quarters · filed 2014-08-13
2014-03-31$101.94M
10-Q · filed 2014-05-14
$102.03M
derived: sum of 2 quarters · filed 2014-05-14
$101.26M
derived: sum of 3 quarters · filed 2014-05-14
$181.75M
derived: sum of 4 quarters · filed 2014-08-13
2013-12-31$94.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
-$676.00K
derived: sum of 2 quarters · filed 2014-02-28
$79.82M
derived: sum of 3 quarters · filed 2014-08-13
$79.95M
10-K · filed 2014-02-28
2013-09-30-$770.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23
$79.72M
derived: sum of 2 quarters · filed 2014-08-13
$79.85M
10-Q · filed 2013-10-23
$79.86M
derived: sum of 4 quarters · filed 2014-08-13
2013-06-30$80.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13
$80.62M
10-Q · filed 2014-08-13
$80.63M
derived: sum of 3 quarters · filed 2014-08-13
$80.63M
derived: sum of 4 quarters · filed 2014-08-13
2013-03-31$130.00K
10-Q · filed 2014-05-14
$135.00K
derived: sum of 2 quarters · filed 2014-05-14
$138.00K
derived: sum of 3 quarters · filed 2014-05-14
2012-12-31$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$8.00K
derived: sum of 2 quarters · filed 2014-02-28
$21.93M
10-K · filed 2014-02-28
2012-09-30$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23
$21.93M
10-Q · filed 2013-10-23
2012-06-30$21.92M
10-Q · filed 2013-08-01
2011-12-31$19.08M
10-K · filed 2014-02-28